Relypsa
A biopharmaceutical company developing drugs to treat cardiovascular and renal diseases
4
Funding Rounds
$178.0m
Money raised
Funding
Funding series
Funding Series Analysis
The company Relypsa has raised a total of $178m in funding over 4 rounds.
Key Insights:
- Relypsa funding round, October 2012: $2.6m
- Relypsa Series C round: $80m
- Relypsa funding round, July 2012: $62.4m
- Relypsa Series A round: $33m
Relypsa funding round, October 2012
$2.6m
Relypsa Series C round
$80m
Relypsa funding round, July 2012
$62.4m
Relypsa Series A round
$33m
Industries
Relypsa is active in the following industries: